Conversely, MLH1 was low in 66% of ERα-negative and 74% of triple-negative breast cancer (TNBC) patient samples, which lack ERα expression (Supplemental Figure 13G). The gene discussed is MLH1; the disease is triple-negative breast carcinoma.